@article{428ae9de831244e38f91a574127ab835,
title = "Editorial: Why are patients with Crohn's disease still treated with 5-aminosalicylates?",
keywords = "Humans, Mesalamine/therapeutic use, Crohn Disease/drug therapy, Remission Induction, Risk Factors",
author = "Johan Burisch",
year = "2023",
month = may,
doi = "10.1111/apt.17450",
language = "English",
volume = "57",
pages = "1044--1045",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "John Wiley and Sons Inc.",
number = "9",
}